TribLIVE

| USWorld


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Doctors pushed into uncharted territory

About The Tribune-Review
The Tribune-Review can be reached via e-mail or at 412-321-6460.
Contact Us | Video | Photo Reprints
Details

An outbreak of fungal meningitis has been linked to steroid shots for back pain. The medication, made by a specialty pharmacy in Massachusetts, has been recalled.

Latest numbers from the Centers for Disease Control and Prevention:

Illnesses: 284, including three joint infections

Deaths: 23

States: 16 — Florida, Idaho, Illinois, Indiana, Maryland, Michigan, Minnesota, New Hampshire, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas and Virginia

Sources: AP; Centers for Disease Control and Prevention

Daily Photo Galleries


By The Washington Post

Published: Saturday, Oct. 20, 2012, 9:02 p.m.

The outbreak of fungal meningitis linked to contaminated steroid injections represents a forced march into unexplored medical territory.

Most fungal infections occur on the skin and are easily treated. Inhaling fungus-contaminated dust sometimes causes pneumonia in healthy people. Fungal infections in the brain, however, are almost always confined to people whose immunity has been suppressed by AIDS, cancer, burns or organ transplantation.

What's under way now — a new form of fungal meningitis in 284 otherwise healthy people — is an event without precedent.

To date, 23 people have died. New cases appear every day; the count increased by 13 on Saturday. In all, 14,000 people in 23 states received injections around the spine or a joint with the anti-inflammatory drug methylprednisolone acetate from three contaminated lots distributed by a Massachusetts company.

“This kind of fungal meningitis has not been reported in the medical literature. There is not enough data to say whether it will be more or less responsive to treatment. We don't know what the outcomes generally are,” said Benjamin Park, a physician in the fungal diseases branch of the Centers for Disease Control and Prevention.

“The truth of the matter is that we don't have any experience with this,” said Arturo Casadevall, an expert on fungal infections and chairman of microbiology and immunology at Albert Einstein College of Medicine in New York.

Fungal infections of the brain are as feared as they are rare. They come on slowly and are hard to diagnose. They require at least three months of therapy with often unpleasant drugs. Treatment failure is common. Survivors are often left with disabilities.

As events unfold, physicians and public health officials are keeping in mind a cluster of five cases of fungal meningitis linked to contaminated injections that occurred a decade ago. One person didn't become ill until 152 days after receiving an injection.

“That's obviously making us concerned about this outbreak,” said Tom M. Chiller, a physician with CDC's fungal diseases branch. “We want patients and providers to continue to be vigilant and on the lookout for symptoms months after the injections.”

 

 
 


Show commenting policy

Most-Read Nation

  1. Colorado deaths stoke marijuana worries
  2. Obama administration delays decision on Keystone XL pipeline
  3. SpaceX supply ship makes Easter cargo delivery to space station
  4. Wyatt Earp gun sells for $225K at auction
  5. Iranian envoy officially blocked by law
  6. Grandmother left vengeful note in boys’ slayings, then committed suicide, police say
  7. Medicaid paid $12M for Illinois dead, audit finds
  8. Judge strikes down Minnesota’s anti-coal law as unconstitutional
  9. Records exonerate ‘X-Men’ director, attorney says
  10. Android systems running 4.1.1 softward carry Heartbleed bug
  11. Authorities say they have trove of evidence against Dzhokhar Tsarnaev in Boston Marathon bombing
Subscribe today! Click here for our subscription offers.